BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chitradevi ST, Kaur G, Uppalapati S, Yadav A, Singh D, Bansal A. Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection. Cell Mol Immunol 2015;12:757-67. [PMID: 25640657 DOI: 10.1038/cmi.2014.86] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 León Y, Zapata L, Salas-burgos A, Oñate A. In silico design of a vaccine candidate based on autotransporters and HSP against the causal agent of shigellosis, Shigella flexneri. Molecular Immunology 2020;121:47-58. [DOI: 10.1016/j.molimm.2020.02.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Arabshahi S, Nayeri Fasaei B, Derakhshandeh A, Novinrooz A. In silico design of a novel chimeric shigella IpaB fused to C terminal of clostridium perfringens enterotoxin as a vaccine candidate. Bioengineered 2018;9:170-7. [PMID: 29091543 DOI: 10.1080/21655979.2017.1373535] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Sagi S, Konduru B, Parida M. Heterologous expression of Intimin and IpaB fusion protein in Lactococcus lactis and its mucosal delivery elicit protection against pathogenicity of Escherichia coli O157 and Shigella flexneri in a murine model. Int Immunopharmacol 2020;85:106617. [PMID: 32464569 DOI: 10.1016/j.intimp.2020.106617] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Baruah N, Ahamad N, Maiti S, Howlader DR, Bhaumik U, Patil VV, Chakrabarti MK, Koley H, Katti DS. Development of a Self-Adjuvanting, Cross-Protective, Stable Intranasal Recombinant Vaccine for Shigellosis. ACS Infect Dis 2021. [PMID: 34734708 DOI: 10.1021/acsinfecdis.1c00345] [Reference Citation Analysis]
5 León Y, Zapata L, Molina RE, Okanovič G, Gómez LA, Daza-Castro C, Flores-Concha M, Reyes JL, Oñate AA. Intranasal Immunization of Mice with Multiepitope Chimeric Vaccine Candidate Based on Conserved Autotransporters SigA, Pic and Sap, Confers Protection against Shigella flexneri. Vaccines (Basel) 2020;8:E563. [PMID: 33019492 DOI: 10.3390/vaccines8040563] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Anam K, Endharti AT, Poeranto S, Sujuti H, Hidayati DYN, Prawiro SR. Shigella flexneri vaccine development: Oral administration of peptides derived from the 49.8 kDa pili protein subunit activates the intestinal immune response in mice. Vet World. [DOI: 10.14202/vetworld.2022.281-287] [Reference Citation Analysis]
7 Verma S, Singh K, Bansal A. Multi-epitope DnaK peptide vaccine accords protection against lethal S. typhimurium challenge: Elicits both cell mediated immunity and long-lasting serum-neutralizing antibody titers. Pharmacol Res 2021;169:105652. [PMID: 33975015 DOI: 10.1016/j.phrs.2021.105652] [Reference Citation Analysis]
8 Turbyfill KR, Clarkson KA, Oaks EV, Kaminski RW. From Concept to Clinical Product: A Brief History of the Novel Shigella Invaplex Vaccine’s Refinement and Evolution. Vaccines 2022;10:548. [DOI: 10.3390/vaccines10040548] [Reference Citation Analysis]
9 Arabshahi S, Derakhshandeh A, Nayeri Fasaei B, Novinrooz A. In-silico design and production of a novel antigenic chimeric Shigella IpaB fused to C-terminal of Clostridium perfringens enterotoxin. Mol Biol Rep 2019;46:6105-15. [PMID: 31473892 DOI: 10.1007/s11033-019-05046-5] [Reference Citation Analysis]
10 Fourie KR, Wilson HL. Understanding GroEL and DnaK Stress Response Proteins as Antigens for Bacterial Diseases. Vaccines (Basel) 2020;8:E773. [PMID: 33348708 DOI: 10.3390/vaccines8040773] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kapoor N, Ndungo E, Pill L, Desalegn G, Berges A, Oaks EV, Fairman J, Pasetti MF. Efficient production of immunologically active Shigella invasion plasmid antigens IpaB and IpaH using a cell-free expression system. Appl Microbiol Biotechnol 2021. [PMID: 34932164 DOI: 10.1007/s00253-021-11701-4] [Reference Citation Analysis]
12 Verma S, Bansal A, Gaur M, Kumar B. Robust immunity induced by multi-epitope DnaK peptides, potential vaccine candidates against Salmonella: An in vitro study. Immunol Lett 2021;236:61-7. [PMID: 34058259 DOI: 10.1016/j.imlet.2021.05.005] [Reference Citation Analysis]